The Lullaby Project as a Musical Intervention for Pregnant Individuals With Epilepsy
Launched by UNIVERSITY HEALTH NETWORK, TORONTO · Aug 13, 2022
Trial Information
Current as of August 22, 2025
Recruiting
Keywords
ClinConnect Summary
The Lullaby Project is a clinical trial designed to explore how music can help pregnant individuals who have epilepsy. The study will involve participants taking part in musical activities coordinated by a music organization in Toronto. Researchers want to see if these musical experiences can improve the quality of life for pregnant women with epilepsy, reduce feelings of depression and anxiety, lower stress, and enhance feelings of empowerment during their pregnancy.
To join the study, participants need to be at least 18 years old, currently pregnant with their first child, and have a confirmed diagnosis of epilepsy. They should also be able to provide consent and have internet access. Participants who are selected will engage in the Lullaby Project and share their experiences, helping researchers understand the potential benefits of music in managing epilepsy during pregnancy. It’s important to note that individuals who have previously participated in the Lullaby Project or need a language interpreter are not eligible for this study.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • at least 18 years of age
- • currently pregnant and primiparous
- • able to provide informed consent
- • able to have internet access
- • have a confirmed diagnosis of epilepsy based on EEG or clinical evidence
- Exclusion Criteria:
- • need of a language interpreter to provide informed consent and/or communicate with the MH-RTH musician
- • prior involvement in the Lullaby Project
About University Health Network, Toronto
University Health Network (UHN), based in Toronto, is a leading academic health sciences center dedicated to advancing patient care through innovative research and education. As a prominent sponsor of clinical trials, UHN integrates cutting-edge scientific discoveries with clinical practice, facilitating the development of new therapies and treatment modalities. With a commitment to improving health outcomes, UHN collaborates with a diverse network of researchers, healthcare professionals, and industry partners, fostering an environment that prioritizes patient safety and ethical standards in clinical research. Through its extensive resources and expertise, UHN plays a pivotal role in transforming healthcare and enhancing the quality of life for patients both locally and globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Toronto, Ontario, Canada
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials